BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 14, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 5, 2019
View Archived Issues
RUNX1 mRNA-containing nanomicelles prevent intervertebral disk degeneration in mice
Read More
BioCryst advancing factor D inhibitor BCX-9930 into clinic for complement-mediated diseases
Read More
Optogenetics helps understand TDP-43 aggregates
Read More
Tackling tendonitis
Read More
PIGU overexpression aids in the prognosis stratification of patients with HCC
Read More
CROI 2019: With additional long-term remission, number of possible HIV cures doubles to 2
Read More
Preliminary phase II data presented for RX-3117 in advanced urothelial cancer
Read More
RCN1 as a novel biomarker of prognosis in non-small cell lung cancer
Read More
PCDHGA7 downregulation in KRAS wild-type colorectal cancer is correlated with poor clinical outcomes
Read More
Ascendis Pharma presents results from phase III heiGHt trial for TransCon hGH
Read More
Nanoparticle MRI contrast agent SN-132D shows preclinical efficacy and safety
Read More
MyoKardia announces safety and efficacy data from PIONEER-OLE study of mavacamten
Read More
PsiOxus initiates first-in-human study of NG-350A
Read More
CARB-X funding to support Contrafect's development of amurins to treat Gram-negative pathogens
Read More
Principia Biopharma reports phase I data for PRN-2246
Read More
FORMA Therapeutics synthesizes new USP28 and USP25 inhibitors
Read More
University of Arizona discloses compounds for Parkinson's disease
Read More
Denali Therapeutics identifies EIF2B activators
Read More
Guangzhou Henovcom Bioscience describes ENPP2 inhibitors
Read More
Harvard College patent describes lincosamide antibiotics
Read More
BioXcel collaborates with Merck KGaA and Pfizer to study avelumab with BXCL-701 and NKTR-214
Read More
Akeso enrolling in phase Ib/II study of AK-104 for advanced solid tumors and gastric cancer
Read More
Grant funds IVI to provide support for typhoid conjugate vaccine studies
Read More
New phase Ib trial explores use of AVID-200 in diffuse cutaneous systemic sclerosis
Read More
FDA clears IND for phase I study of KO-539 in relapsed or refractory AML
Read More